Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: Analysis by the centerline method with correction for area at risk

This publication has 31 references indexed in Scilit:

• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• Prognosis and Management after a First Myocardial Infarction
  New England Journal of Medicine, 1990
• Does vessel patency at the time of hospital discharge following thrombolytic therapy predict survival?
  Journal of the American College of Cardiology, 1990
• Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands
  Journal of the American College of Cardiology, 1989
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988
• Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
  Circulation, 1987
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)
  New England Journal of Medicine, 1986
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985